Finazzi-Agr Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
The honest summary is that the biology is sound and the early signals are encouraging, but the proof most of us would want, consistent results in robust human trials, is still being built
Since retatrutide has gotten a lot of attention, some people are trying to get it outside of approved medical channels
The researchers noted that this peptide elevated melatonin levels in the participants, leading to improved regulation of their sleep patterns [14]